Author(s):
G. Sai Kiran, U. Sahithi Puja, Doondi Phani Kumar, A. Pravalika, Ch. Bhargav Sai
Email(s):
uppaluru.sahithipuja@gmail.com
DOI:
10.5958/0974-360X.2020.01002.1 
Address:
G. Sai Kiran1, U. Sahithi Puja2*, Doondi Phani Kumar2, A. Pravalika2, Ch. Bhargav Sai2
1Assistant Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Atmakur, Mangalagiri, Guntur (Dist)-522503.
2Pharm D Students, Nirmala College of Pharmacy, Atmakur, Mangalagiri, Guntur (Dist)-522503.
*Corresponding Author
Published In:
Volume - 13,
Issue - 12,
Year - 2020
ABSTRACT:
Denis Burkitt found the first case of a "lymphoma" in children from the region of Africa, which double its size every 24 hours. A Nineteen years male adolescent was admitted in the hospital with the chief complaints of high-grade fever along with Fatigue, Giddiness. The most common treatment for BL is intensive chemotherapy, which usually lasts for a month, but may also last up to 8 months. Children with BL having survival rates better than adults. Burkitt's lymphoma is associated with a particular translocation t(8:14)(q24:q23) that juxtaposes the MYC/c-Myc gene (8q24). It represents around half of all malignant non-Hodgkin's lymphoma in children and around 2% in adults in Europe and North America. In Africa, BL accounts for 30-50% of all childhood cancer. the standard treatment for BL is intensive chemotherapy, which usually lasts for a month, but may also last up to 8 months. When diagnosed early, the survival rate higher than 90%. Most of the physicians will choose chemotherapy and some other treatment options based on disease complexity and patient progress. This information might be helpful.
Cite this article:
G. Sai Kiran, U. Sahithi Puja, Doondi Phani Kumar, A. Pravalika, Ch. Bhargav Sai. Translocation of C-MYC gene by expressed eighty percentage of Tumour cells cause abdominal Burkitt’s lymphoma during the third phase of chemotherapy it Relapsed: A Case report and Literature. Research J. Pharm. and Tech. 2020; 13(12):5754-5756. doi: 10.5958/0974-360X.2020.01002.1
Cite(Electronic):
G. Sai Kiran, U. Sahithi Puja, Doondi Phani Kumar, A. Pravalika, Ch. Bhargav Sai. Translocation of C-MYC gene by expressed eighty percentage of Tumour cells cause abdominal Burkitt’s lymphoma during the third phase of chemotherapy it Relapsed: A Case report and Literature. Research J. Pharm. and Tech. 2020; 13(12):5754-5756. doi: 10.5958/0974-360X.2020.01002.1 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-12-17
REFERENCES:
1. Burkitt D. Malignant Lymphomata Involving the Jaws in Africa. J Laryngol Otol. 1965;79(11): 929-39.
2. Ardekian L, Peleg M, Samet N, Givol N, Taicher S. Burkitt's lymphoma is mimicking an acute dentoalveolar abscess. J Endod. 1996; 22(12): 697-98.
3. Ugboko V, Ndukwe K, Adelusola K, Durosinmi M. Burkitt's lymphoma presenting as lower lip paraesthesia in a 24-year-old Nigerian. Case report. Aust. Dent. J. 1999; 44(1): 58-60.
4. Magrath I, Jaffe ES, Bhatia K. Burkitt's lymphoma. In: Knowles DM, editor. Neoplastic Hematopathology. Philadelphia, PA: Lippincott Williams and Wilkins; 2001: 953–86.
5. Burkitt Lymphoma - Blood Disorders - MSD Manual Consumer Version. (2020). Retrieved 1 February 2020, from https://www.merckmanuals.com/home/blood-disorders/lymphomas/burkitt-lymphoma
6. Magrath IT. Burkitt's lymphoma. The small noncleaved cell lymphomas. In: Canellos GP, Lister TA, Sklar JL, editors. The Lymphomas. Philadelphia, PA: WB Saunders; 1998:413–22.
7. Swerdlow S, Campo E, Pileri S, Harris N, Stein H, Siebert R, World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20): 2375-90.
8. Burkitt Lymphoma and Burkitt-like Lymphoma: Practice Essentials, Background, Etiology, and Pathophysiology. (2020). Retrieved 1 February 2020, from http://emedicine.medscape.com/article/1447602-overview.
9. Burkitt Lymphoma - Hematology and Oncology - MSD Manual Professional Edition. (2020). Retrieved 1 February 2020, from http://www.merckmanuals.com/professional/hematology-and-oncology/lymphomas/burkitt-lymphoma.
10. Dunleavy K, e. (2020). Update on Burkitt Lymphoma. - PubMed - NCBI. Retrieved 1 February 2020, from https:// www.ncbi.nlm.nih.gov/pubmed/27888884.
11. Freedman AS, Aster JC. Epidemiology, clinical manifestations, pathologic features, and diagnosis of Burkitt lymphoma. UpToDate. Waltham, MA: UpToDate; August 2017; UpToDate. (2020). Retrieved 1 February 2020, from https://www.uptodate.com/contents/epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-burkitt-lymphoma.
12. Lymphoma Action | Burkitt lymphoma [Internet]. Lymphoma Action. 2020 [cited 15 January 2020]. Available from: https://lymphoma-action.org.uk/types-lymphoma-non-hodgkin-lymphoma/burkitt-lymphoma.
13. Burkitt Lymphoma [Internet]. Dove Med. 2020 [cited 15 January 2020]. Available from: https://www.dovemed.com/diseases-conditions/burkitt-lymphoma/
14. Orphanet: Burkitt lymphoma [Internet]. Orpha.net. 2020 [cited 15 January 2020]. Available from: https://www.orpha.net/consor/cgi-bin/Disease_Search.php? lng=ENanddata_id=3747andMISSING%20CONTENT=Burkitt-lymphoma and search=Disease_Search_Simple and title= Burkitt%20lymphoma#
15. Stefan, D., and Lutchman. Burkitt lymphoma: epidemiological features and survival in a South African centre. Infect Agent Cancer. (2014): 9(1)
16. UpToDate®. Oncology Times. 2019;41(4):16.
17. Casulo C, Friedberg J. Treating Burkitt Lymphoma in Adults. Curr Hematol Malig Rep. September 2015; 10(3):266-71.
18. Burkitt Lymphoma - Blood Disorders - MSD Manual Consumer Version. (2020). Retrieved 1 February 2020, from http://www.merckmanuals.com/home/blood-disorders/ lymphomas/burkitt-lymphoma.
19. MD Jon C Aster, A. (2020). Up to Date. Retrieved 1 February 2020, from https://www.uptodate.com/contents/epidemiology-clinical-manifestations-pathologic-features-and-diagnosis-of-burkitt